Monoclonal antibodies, or mAbs, are important tools in medicine. These laboratory-made proteins are widely used in treatments ...

An emergency room doctor has shared the 10 early warning signs you or a loved one might have developed Alzheimer's disease - as he urges people to visit their doctors ...

In this week’s edition of InnovationRx, we look at HHS nominee Robert F. Kennedy Jr.’s first Senate confirmation hearing, the ...

Alzheimer’s affects millions of Americans and can have a devastating impact on finances. Some of the worst damage is done before a diagnosis is even made.

A delay in getting to the rapid eye movement (REM) stage of sleep may be linked to Alzheimer's disease and related dementias, ...

The approval adds a new indication for GLP-1 drugs and gives Novo an advantage over Lilly’s rival diabetes drug Mounjaro, ...

Research indicates longer REM latency is associated with higher Alzheimer's biomarkers, pointing to its potential as an early ...

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

Except that’s not how we human beings process the information, according to a new research paper. Telling people that a ...

There are two kinds of risk factors for dementia: non-modifiable and modifiable. Non-modifiable risk factors are ones that cannot be changed or eliminated, like aging, family history and genetics.

The Trump Administration’s abrupt cancellation of National Institutes of Health meetings and grant reviews has sparked ...